Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/14/2025

Management of Mild Hyperbilirubinemia in Breastfeeding Infants

Assessment of Bilirubin Levels

  • The American Academy of Pediatrics recommends that a direct bilirubin level of 0.4 mg/dL is within normal limits, as it does not exceed 1.0 mg/dL when the total bilirubin is below 5 mg/dL 2
  • The indirect bilirubin level of 2.4 mg/dL is not concerning at this age and represents physiologic jaundice that is resolving 1

Management Approach

  • The American Academy of Pediatrics recommends continuing breastfeeding without interruption as these bilirubin levels do not warrant intervention 3, 4
  • Ensure adequate breastfeeding frequency (8-12 times per day) to promote optimal milk intake and bilirubin clearance 5, 3
  • No phototherapy is indicated as the total bilirubin level is well below treatment thresholds 3, 1
  • No supplementation with formula is necessary unless there are signs of inadequate intake 4

Monitoring

  • Assess for adequate breastfeeding by monitoring weight and percent change from birth weight 1
  • Assess for adequate breastfeeding by monitoring pattern of voiding (6-8 wet diapers per day) 1
  • No further bilirubin testing is needed unless clinical jaundice worsens or other concerning symptoms develop 6, 1

Important Caveats

  • If the infant shows poor weight gain, inadequate intake, or dehydration, more frequent follow-up would be warranted 4, 1
  • If jaundice persists beyond 3 weeks with rising direct bilirubin, further evaluation for cholestasis would be indicated 6

Follow-up Recommendations

  • Continue routine well-child care without specific follow-up for jaundice 1
  • Reassess if clinical jaundice worsens or if there are concerns about feeding, weight gain, or development 1